Long-term treatment with atrial natriuretic peptide inhibits ATP production and insulin secretion in rat pancreatic islets

American Journal of Physiology - Endocrinology and Metabolism

Volumn 300, Issue 3, 2011, Pages

  You, Hui ^a   Laychock, Suzanne G ^a  

^a UNIVERSITY AT BUFFALO   (United States)

Author keywords

Adenosine triphosphate adenosine diphosphate ratio; Cyclic guanosine monophosphate; Guanylyl cyclase; Islets of langerhans; Natriuretic peptide receptor A

Indexed keywords

2 OXOISOCAPROIC ACID; ADENOSINE TRIPHOSPHATE; ATRIAL NATRIURETIC FACTOR; FORSKOLIN; GLUCOSE; HORMONE SENSITIVE LIPASE; IONOMYCIN; NATRIURETIC PEPTIDE RECEPTOR A; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; POTASSIUM CHLORIDE; UNCOUPLING PROTEIN 2;

ANIMAL CELL; ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DIABETES MELLITUS; ENZYME ACTIVATION; ENZYME LINKED IMMUNOSORBENT ASSAY; GLUCOSE UTILIZATION; GLYCOLYSIS; HYPERGLYCEMIA; IMMUNOBLOTTING; INCUBATION TIME; INSULIN RELEASE; NONHUMAN; PANCREAS ISLET BETA CELL; PRIORITY JOURNAL; RAT; REAL TIME POLYMERASE CHAIN REACTION;

ADENOSINE DIPHOSPHATE; ADENOSINE TRIPHOSPHATE; ANIMALS; ATRIAL NATRIURETIC FACTOR; BLOTTING, WESTERN; CYCLIC GMP; ENZYME-LINKED IMMUNOSORBENT ASSAY; FORSKOLIN; GLUCOSE; INSULIN; ISLETS OF LANGERHANS; KETO ACIDS; MALE; POTASSIUM CHLORIDE; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, ATRIAL NATRIURETIC FACTOR; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA;

EID: 79952177198     PISSN: 01931849     EISSN: 15221555     Source Type: Journal    
DOI: 10.1152/ajpendo.00398.2010     Document Type: Article

References (63)

1. Ahren B. ANF inhibits glucose-stimulated insulin secretion in mouse and rat. Am J Physiol Endocrinol Metab 255: E579-E582, 1988.
2. Ashcroft FM. ATP-sensitive potassium channelopathies: focus on insulin secretion. J Clin Invest 115: 2047-2058, 2005. (Pubitemid 41134141)
3. Ashcroft FM, Harrison DE, Ashcroft SJ. Glucose induces closure of single potassium channels in isolated rat pancreatic beta-cells. Nature 312: 446-448, 1984. (Pubitemid 15217837)
4. Bernal-Mizrachi E, Fatrai S, Johnson JD, Ohsugi M, Otani K, Han Z, Polonsky KS, Permutt MA. Defective insulin secretion and increased susceptibility to experimental diabetes are induced by reduced Akt activity in pancreatic islet beta cells. J Clin Invest 114: 928-936, 2004. (Pubitemid 39578720)
5. Burgess MD, Moore KD, Carter GM, Alli AA, Granda CS, Ichii H, Ricordi C, Gower WR Jr. C-type natriuretic peptide receptor expression in pancreatic alpha cells. Histochem Cell Biol 132: 95-103, 2009.
6. Carvajal JA, Germain AM, Huidobro-Toro JP, Weiner CP. Molecular mechanism of cGMP-mediated smooth muscle relaxation. J Cell Physiol 184: 409-420, 2000. (Pubitemid 30625505)
7. Chan CB, De Leo D, Joseph JW, McQuaid TS, Ha XF, Xu F, Tsushima RG, Pennefather PS, Salapatek AM, Wheeler MB. Increased uncoupling protein-2 levels in beta-cells are associated with impaired glucose-stimulated insulin secretion: mechanism of action. Diabetes 50: 1302-1310, 2001. (Pubitemid 32500162)
8. Charles MA, Fanska R, Schmid FG, Forsham PH, Grodsky GM. Adenosine 3′,5′-monophosphate in pancreatic islets: glucose-induced insulin release. Science 179: 569-571, 1973.
9. 2+ and the ATP/ADP ratio: a feedback control mechanism in mouse pancreatic islets. Biochem J 333: 269-274, 1998.
10. Dimmeler S, Fleming I, Fisslthaler B, Hermann C, Busse R, Zeiher AM. Activation of nitric oxide synthase in endothelial cells by Akt-dependent phosphorylation. Nature 399: 601-605, 1999.
11. Fadda GZ, Hajjar SM, Perna AF, Zhou XJ, Lipson LG, Massry SG. On the mechanism of impaired insulin secretion in chronic renal failure. J Clin Invest 87: 255-261, 1991.
12. Gao Z, Young RA, Li G, Najafi H, Buettger C, Sukumvanich SS, Wong RK, Wolf BA, Matschinsky FM. Distinguishing features of leucine and alpha-ketoisocaproate sensing in pancreatic beta-cells. Endocrinology 144: 1949-1957, 2003.
13. Gao Z, Yuen PS, Garbers DL. Interruption of specific guanylyl cyclase signaling pathways. Adv Second Messenger Phosphoprotein Res 31: 183-190, 1997.
14. Giroix MH, Agascioglu E, Oguzhan B, Louchami K, Zhang Y, Courtois P, Malaisse WJ, Sener A. Opposite effects of D-fructose on total versus cytosolic ATP/ADP ratio in pancreatic islet cells. Biochim Biophys Acta 1757: 773-780, 2006. (Pubitemid 44142420)
15. Hatlapatka K, Willenborg M, Rustenbeck I. Plasma membrane depolarization as a determinant of the first phase of insulin secretion. Am J Physiol Endocrinol Metab 297: E315-E322, 2009.
16. Hedeskov CJ. Mechanism of glucose-induced insulin secretion. Physiol Rev 60: 442-509, 1980. (Pubitemid 10091895)
17. Henquin JC, Meissner HP. The ionic, electrical, and secretory effects of endogenous cyclic adenosine monophosphate in mouse pancreatic B cells: studies with forskolin. Endocrinology 115: 1125-1134, 1984. (Pubitemid 14074485)
18. Jaburek M, Varecha M, Gimeno RE, Dembski M, Jezek P, Zhang M, Burn P, Tartaglia LA, Garlid KD. Transport function and regulation of mitochondrial uncoupling proteins 2 and 3. J Biol Chem 274: 26003-26007, 1999.
19. Khoo JC, Sperry PJ, Gill GN, Steinberg D. Activation of hormone-sensitive lipase and phosphorylase kinase by purified cyclic GMP-dependent protein kinase. Proc Natl Acad Sci USA 74: 4843-4847, 1977. (Pubitemid 8227020)
20. Koyama K, Chen G, Wang MY, Lee Y, Shimabukuro M, Newgard CB, Unger RH. beta-cell function in normal rats made chronically hyperleptinemic by adenovirus-leptin gene therapy. Diabetes 46: 1276-1280, 1997. (Pubitemid 27315275)
21. Laychock SG. Effects of guanosine 3=,5=-monophosphate on glucose utilization in isolated islets of Langerhans. Endocrinology 120: 517-524, 1987. (Pubitemid 17020402)
22. Laychock SG. Evidence for guanosine 3′,5′-monophosphate as a putative mediator of insulin secretion from isolated rat islets. Endocrinology 108: 1197-1205, 1981. (Pubitemid 11079135)
23. Laychock SG. Mediation of insulin release by cGMP and cAMP in a starved animal model. Mol Cell Endocrinol 32: 157-170, 1983. (Pubitemid 13022063)
24. Lee B, Jonas JC, Weir GC, Laychock SG. Glucose regulates expression of inositol 1,4,5-trisphosphate receptor isoforms in isolated rat pancreatic islets. Endocrinology 140: 2173-2182, 1999. (Pubitemid 30636457)
25. 2+)-ATPase activity. Diabetes 46: 1312-1318, 1997.
26. Lenzen S, Formanek H, Panten U. Signal function of metabolism of neutral amino acids and 2-keto acids for initiation of insulin secretion. J Biol Chem 257: 6631-6633, 1982. (Pubitemid 12022259)
27. Li J, Luo R, Kowluru A, Li G. Novel regulation by Rac1 of glucose- and forskolin-induced insulin secretion in INS-1 β-cells. Am J Physiol Endocrinol Metab 286: E818-E827, 2004. (Pubitemid 38514676)
28. Malaisse WJ, Garcia-Morales P, Dufrane SP, Sener A, Valverde I. Forskolin-induced activation of adenylate cyclase, cyclic adenosine monophosphate production and insulin release in rat pancreatic islets. Endocrinology 115: 2015-2020, 1984. (Pubitemid 15206627)
29. Malaisse WJ, Sener A, Malaisse-Legae F, Hutton JC, Christophe J. The stimulus-secretion coupling of amino acid-induced insulin release. Metabolic interaction of L-glutamine and 2-ketoisocaproate in pancreatic islets. Biochim Biophys Acta 677: 39-49, 1981.
30. Matsubara H, Mori Y, Yamamoto J, Inada M. Diabetes-induced alterations in atrial natriuretic peptide gene expression in Wistar-Kyoto and spontaneously hypertensive rats. Circ Res 67: 803-813, 1990. (Pubitemid 20315012)
31. McKenna K, Smith D, Tormey W, Thompson CJ. Acute hyperglycaemia causes elevation in plasma atrial natriuretic peptide concentrations in Type 1 diabetes mellitus. Diabet Med 17: 512-517, 2000. (Pubitemid 30660152)
32. Mouawad R, Li Y, Anand-Srivastava MB. Atrial natriuretic peptide-C receptor-induced attenuation of adenylyl cyclase signaling activates phosphatidylinositol turnover in A10 vascular smooth muscle cells. Mol Pharmacol 65: 917-924, 2004. (Pubitemid 38420497)
33. Ortola FV, Ballermann BJ, Anderson S, Mendez RE, Brenner BM. Elevated plasma atrial natriuretic peptide levels in diabetic rats. Potential mediator of hyperfiltration. J Clin Invest 80: 670-674, 1987. (Pubitemid 18003936)
34. Patane G, Anello M, Piro S, Vigneri R, Purrello F, Rabuazzo AM. Role of ATP production and uncoupling protein-2 in the insulin secretory defect induced by chronic exposure to high glucose or free fatty acids and effects of peroxisome proliferator-activated receptor-gamma inhibition. Diabetes 51: 2749-2756, 2002. (Pubitemid 34970928)
35. Potter LR, Abbey-Hosch S, Dickey DM. Natriuretic peptides, their receptors, and cyclic guanosine monophosphate-dependent signaling functions. Endocr Rev 27: 47-72, 2006. (Pubitemid 43228238)
36. Radosavljevic T, Todorovic V, Sikic B. [Insulin secretion: mechanisms of regulation]. Med Pregl 57: 249-253, 2004.
37. Rasmussen H, Barrett PQ. Calcium messenger system: an integrated view. Physiol Rev 64: 938-984, 1984. (Pubitemid 14084548)
38. Renstrom E, Eliasson L, Rorsman P. Protein kinase A-dependent and -independent stimulation of exocytosis by cAMP in mouse pancreatic B-cells. J Physiol 502: 105-118, 1997. (Pubitemid 27322979)
39. Ropero AB, Soriano S, Tuduri E, Marroqui L, Tellez N, Gassner B, Juan-Pico P, Montanya E, Quesada I, Kuhn M, Nadal A. The atrial natriuretic peptide and guanylyl cyclase-A system modulates pancreatic beta-cell function. Endocrinology 151: 3665-3674, 2010.
40. Schoonjans K, Staels B, Auwerx J. Role of the peroxisome proliferator-activated receptor (PPAR) in mediating the effects of fibrates and fatty acids on gene expression. J Lipid Res 37: 907-925, 1996. (Pubitemid 26182326)
41. Schultz V, Sussman I, Bokvist K, Tornheim K. Bioluminometric assay of ADP and ATP at high ATP/ADP ratios: assay of ADP after enzymatic removal of ATP. Anal Biochem 215: 302-304, 1993. (Pubitemid 23360921)
42. Sengenes C, Bouloumie A, Hauner H, Berlan M, Busse R, Lafontan M, Galitzky J. Involvement of a cGMP-dependent pathway in the natriuretic peptide-mediated hormone-sensitive lipase phosphorylation in human adipocytes. J Biol Chem 278: 48617-48626, 2003. (Pubitemid 41079500)
43. Shi Y, Chen X, Wu Z, Shi W, Yang Y, Cui N, Jiang C, Harrison RW. cAMP-dependent protein kinase phosphorylation produces interdomain movement in SUR2B leading to activation of the vascular KATP channel. J Biol Chem 283: 7523-7530, 2008.
44. Sweet IR, Gilbert M. Contribution of calcium influx in mediating glucose-stimulated oxygen consumption in pancreatic islets. Diabetes 55: 3509-3519, 2006. (Pubitemid 44923612)
45. + channel-independent glucose action. Endocrinology 136: 3942-3948, 1995.
46. + channel: a pas de deux. Diabetes 53, Suppl 3: S113-S122, 2004.
47. Tordjman K, Standley KN, Bernal-Mizrachi C, Leone TC, Coleman T, Kelly DP, Semenkovich CF. PPARalpha suppresses insulin secretion and induces UCP2 in insulinoma cells. J Lipid Res 43: 936-943, 2002. (Pubitemid 34602616)
48. Torii S, Zhao S, Yi Z, Takeuchi T, Izumi T. Granuphilin modulates the exocytosis of secretory granules through interaction with syntaxin 1a. Mol Cell Biol 22: 5518-5526, 2002. (Pubitemid 34755761)
49. Tung P, Pai G, Johnson DG, Punzalan R, Levin SR. Relationships between adenylate cyclase and Na(+),K(+)-ATPase in rat pancreatic islets. J Biol Chem 265: 3936-3939, 1990.
50. Uehlinger DE, Weidmann P, Gnadinger MP, Hasler L, Bachmann C, Shaw S, Hellmuller B, Lang RE. Increase in circulating insulin induced by atrial natriuretic peptide in normal humans. J Cardiovasc Pharmacol 8: 1122-1129, 1986. (Pubitemid 17211574)
51. Verspohl EJ, Ammon HP. Atrial natriuretic peptide (ANP) acts via specific binding sites on cGMP system of rat pancreatic islets without affecting insulin release. Naunyn Schmiedebergs Arch Pharmacol 339: 348-353, 1989. (Pubitemid 19094824)
52. Verspohl EJ, Bernemann IK. Atrial natriuretic peptide (ANP)-induced inhibition of glucagon secretion: mechanism of action in isolated rat pancreatic islets. Peptides 17: 1023-1029, 1996. (Pubitemid 26355330)
53. Verspohl EJ, Kuhn M, Ammon HP. RIN m5F (rat insulinoma) cells possess receptors for atrial natriuretic peptide (ANP) and a functioning cGMP system. Horm Metab Res 20: 700-701, 1988.
54. Villarroya F, Iglesias R, Giralt M. PPARs in the control of uncoupling proteins gene expression. PPAR Res 2007: 74364, 2007.
55. Winzell MS, Svensson H, Arner P, Ahren B, Holm C. The expression of hormone-sensitive lipase in clonal beta-cells and rat islets is induced by long-term exposure to high glucose. Diabetes 50: 2225-2230, 2001. (Pubitemid 33641905)
56. Wollheim CB, Pozzan T. Correlation between cytosolic free Ca2+ and insulin release in an insulin-secreting cell line. J Biol Chem 259: 2262-2267, 1984. (Pubitemid 14190341)
57. Xia M, Laychock SG. Insulin secretion, myo-inositol transport, and Na(+)-K(+)-ATPase in glucose-desensitized rat islets. Diabetes 42: 1392-1400, 1993. (Pubitemid 23277194)
58. + channel-independent pathway of glucose signaling in rat pancreatic islets. Diabetes 48: 1006-1012, 1999.
59. You H, Laychock SG. Atrial natriuretic peptide promotes pancreatic islet beta-cell growth and Akt/Foxo1a/cyclin D2 signaling. Endocrinology 150: 5455-5465, 2009.
60. Zawalich WS, Tesz GJ, Zawalich KC. Inhibitors of phosphatidylinositol 3-kinase amplify insulin release from islets of lean but not obese mice. J Endocrinol 174: 247-258, 2002. (Pubitemid 34965763)
61. Zhang CY, Baffy G, Perret P, Krauss S, Peroni O, Grujic D, Hagen T, Vidal-Puig AJ, Boss O, Kim YB, Zheng XX, Wheeler MB, Shulman GI, Chan CB, Lowell BB. Uncoupling protein-2 negatively regulates insulin secretion and is a major link between obesity, beta cell dysfunction, and type 2 diabetes. Cell 105: 745-755, 2001. (Pubitemid 32635104)
62. Zhou YP, Grill VE. Long-term exposure of rat pancreatic islets to fatty acids inhibits glucose-induced insulin secretion and biosynthesis through a glucose fatty acid cycle. J Clin Invest 93: 870-876, 1994. (Pubitemid 24072831)
63. Zhou YT, Shimabukuro M, Wang MY, Lee Y, Higa M, Milburn JL, Newgard CB, Unger RH. Role of peroxisome proliferator-activated receptor alpha in disease of pancreatic beta cells. Proc Natl Acad Sci USA 95: 8898-8903, 1998. (Pubitemid 28350586)